{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T16:34:54Z","timestamp":1780504494525,"version":"3.54.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["305064\/2011-8"],"award-info":[{"award-number":["305064\/2011-8"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["232711\/2014-3"],"award-info":[{"award-number":["232711\/2014-3"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","award":["9028-11-0"],"award-info":[{"award-number":["9028-11-0"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","award":["2011\/12448-0"],"award-info":[{"award-number":["2011\/12448-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.clim.2016.10.004","type":"journal-article","created":{"date-parts":[[2016,10,16]],"date-time":"2016-10-16T17:06:20Z","timestamp":1476637580000},"page":"149-156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Differential capacity of therapeutic drugs to induce Rods\/Rings structures in vitro and in vivo and generation of anti-Rods\/Rings autoantibodies"],"prefix":"10.1016","volume":"173","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0660-2857","authenticated-orcid":false,"given":"Gerson Dierley","family":"Keppeke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica Simon","family":"Prado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunice","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1203-8287","authenticated-orcid":false,"given":"Sandro Felix","family":"Perazzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Helena","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Lucia Gomes","family":"Ferraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward K L","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8742-9931","authenticated-orcid":false,"given":"Luis Eduardo Coelho","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2016.10.004_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045392","article-title":"Longitudinal study of a human drug-induced model of autoantibody to cytoplasmic rods\/rings following HCV therapy with ribavirin and interferon-alpha","volume":"7","author":"Keppeke","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2016.10.004_bb0010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fimmu.2015.00041","article-title":"Anti-rods\/rings: a human model of drug-induced autoantibody generation","volume":"6","author":"Calise","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2016.10.004_bb0015","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/B978-0-12-800097-7.00002-6","article-title":"Molecular cell biology and immunobiology of mammalian rod\/ring structures","volume":"308","author":"Carcamo","year":"2014","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"10.1016\/j.clim.2016.10.004_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029690","article-title":"Induction of cytoplasmic rods and rings structures by inhibition of the CTP and GTP synthetic pathway in mammalian cells","volume":"6","author":"Carcamo","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2016.10.004_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051096","article-title":"Different characteristics and nucleotide binding properties of inosine monophosphate dehydrogenase (IMPDH) isoforms","volume":"7","author":"Thomas","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2016.10.004_bb0030","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1673-8527(09)60046-1","article-title":"Intracellular compartmentation of CTP synthase in Drosophila","volume":"37","author":"Liu","year":"2010","journal-title":"J. Genet. Genom."},{"key":"10.1016\/j.clim.2016.10.004_bb0035","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1369\/0022155414543853","article-title":"Ultrastructure of cytoplasmic and nuclear inosine-5\u2032-monophosphate dehydrogenase 2 \u201crods and rings\u201d inclusions","volume":"62","author":"Juda","year":"2014","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.clim.2016.10.004_bb0040","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s10875-012-9827-4","article-title":"Differential reactivity to IMPDH2 by anti-rods\/rings autoantibodies and unresponsiveness to pegylated interferon-alpha\/ribavirin therapy in US and Italian HCV patients","volume":"33","author":"Carcamo","year":"2013","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2016.10.004_bb0045","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3851\/IMP1993","article-title":"Cytoplasmic rods and rings autoantibodies developed during pegylated interferon and ribavirin therapy in patients with chronic hepatitis C","volume":"17","author":"Covini","year":"2012","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.clim.2016.10.004_bb0050","first-page":"753","article-title":"Autoantibodies against inosine-5\u2032-monophosphate dehydrogenase 2-characteristics and prevalence in patients with HCV-infection","volume":"57","author":"Seelig","year":"2011","journal-title":"Clin. Lab."},{"key":"10.1016\/j.clim.2016.10.004_bb0055","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.cca.2013.01.003","article-title":"Development of a recombinant cell-based indirect immunofluorescence assay (RC-IFA) for the determination of autoantibodies against \u201crings and rods\u201d-associated inosine-5\u2032-monophosphate dehydrogenase 2 in viral hepatitis C","volume":"418","author":"Probst","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.clim.2016.10.004_bb0060","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s12026-014-8515-2","article-title":"Temporal evolution of human autoantibody response to cytoplasmic rods and rings structure during anti-HCV therapy with ribavirin and interferon-alpha","volume":"60","author":"Keppeke","year":"2014","journal-title":"Immunol. Res."},{"key":"10.1016\/j.clim.2016.10.004_bb0065","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.3748\/wjg.v22.i6.1966","article-title":"Anti-rods\/rings autoantibody generation in hepatitis C patients during interferon-alpha\/ribavirin therapy","volume":"22","author":"Keppeke","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.clim.2016.10.004_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2045-3701-5-1","article-title":"Microinjection of specific anti-IMPDH2 antibodies induces disassembly of cytoplasmic rods\/rings that are primarily stationary and stable structures","volume":"5","author":"Keppeke","year":"2015","journal-title":"Cell Biosci."},{"key":"10.1016\/j.clim.2016.10.004_bb0075","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1007\/s00018-014-1567-6","article-title":"Glutamine deprivation initiates reversible assembly of mammalian rods and rings","volume":"71","author":"Calise","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.clim.2016.10.004_bb0080","doi-asserted-by":"crossref","first-page":"R182","DOI":"10.1186\/ar2093","article-title":"Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis","volume":"8","author":"Moore","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clim.2016.10.004_bb0085","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/TP.0b013e3181952623","article-title":"Mycophenolate mofetil decreases acute rejection and may improve graft survival in renal transplant recipients when compared with azathioprine: a systematic review","volume":"87","author":"Knight","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.clim.2016.10.004_bb0090","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/01.bor.0000135453.70424.1b","article-title":"Interferon-alpha in systemic lupus erythematosus","volume":"16","author":"Crow","year":"2004","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.clim.2016.10.004_bb0095","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2016.10.004_bb0100","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2016.10.004_bb0105","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2016.10.004_bb0110","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1074\/jbc.M507056200","article-title":"Regulation of the interaction of inosine monophosphate dehydrogenase with mycophenolic acid by GTP","volume":"281","author":"Ji","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2016.10.004_bb0115","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/j.biocel.2007.12.018","article-title":"Characterisation of inosine monophosphate dehydrogenase expression during retinal development: differences between variants and isoforms","volume":"40","author":"Gunter","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.clim.2016.10.004_bb0120","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1242\/jcs.175265","article-title":"Cytoophidium assembly reflects upregulation of IMPDH activity","volume":"128","author":"Chang","year":"2015","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.clim.2016.10.004_bb0125","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1128\/AAC.44.4.859-866.2000","article-title":"Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: a comparison with ribavirin and demonstration of antiviral additivity with alpha interferon","volume":"44","author":"Markland","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.clim.2016.10.004_bb0130","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1021\/cr900021w","article-title":"IMP dehydrogenase: structure, mechanism, and inhibition","volume":"109","author":"Hedstrom","year":"2009","journal-title":"Chem. Rev."},{"key":"10.1016\/j.clim.2016.10.004_bb0135","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0092-8674(00)81275-1","article-title":"Structure and mechanism of inosine monophosphate dehydrogenase in complex with the immunosuppressant mycophenolic acid","volume":"85","author":"Sintchak","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.clim.2016.10.004_bb0140","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1172\/JCI200318384","article-title":"Azathioprine: old drug, new actions","volume":"111","author":"Maltzman","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2016.10.004_bb0145","first-page":"RA247","article-title":"Reviewing the mechanism of action of thiopurine drugs: towards a new paradigm in clinical practice","volume":"10","author":"Cara","year":"2004","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.clim.2016.10.004_bb0150","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.183400","article-title":"Rod and ring formation from IMP dehydrogenase is regulated via the one-carbon metabolic pathway","author":"Calise","year":"2016","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.clim.2016.10.004_bb0155","doi-asserted-by":"crossref","first-page":"8923","DOI":"10.1038\/ncomms9923","article-title":"Guanine nucleotide binding to the Bateman domain mediates the allosteric inhibition of eukaryotic IMP dehydrogenases","volume":"6","author":"Buey","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.clim.2016.10.004_bb0160","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jgg.2015.04.002","article-title":"Assembly of IMPDH2-based, CTPS-based, and mixed rod\/ring structures is dependent on cell type and conditions of induction","volume":"42","author":"Keppeke","year":"2015","journal-title":"J. Genet. Genom."},{"key":"10.1016\/j.clim.2016.10.004_bb0165","doi-asserted-by":"crossref","first-page":"19421","DOI":"10.1074\/jbc.271.32.19421","article-title":"Conformational changes and stabilization of inosine 5\u2032-monophosphate dehydrogenase associated with ligand binding and inhibition by mycophenolic acid","volume":"271","author":"Nimmesgern","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2016.10.004_bb0170","series-title":"Autoantibodies (Third Edition)","first-page":"161","article-title":"Chapter 19 - antibodies to rods and rings","author":"Calise","year":"2014"},{"key":"10.1016\/j.clim.2016.10.004_bb0175","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1002\/art.34380","article-title":"Prevalence and sociodemographic correlates of antinuclear antibodies in the United States","volume":"64","author":"Satoh","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2016.10.004_bb0180","first-page":"1","article-title":"Clinical correlates of the \u201crods and rings\u201d antinuclear antibody pattern","author":"Climent","year":"2015","journal-title":"Autoimmunity"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661616302297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661616302297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T14:15:59Z","timestamp":1582553759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661616302297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":36,"alternative-id":["S1521661616302297"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2016.10.004","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential capacity of therapeutic drugs to induce Rods\/Rings structures in vitro and in vivo and generation of anti-Rods\/Rings autoantibodies","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2016.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}